Stat3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| STAT3 Gene | |
|---|---|
| Full Name | Signal Transducer and Activator of Transcription 3 |
| Chromosome | 17q21.2 |
| NCBI Gene ID | 6776 |
| OMIM | 102582 |
| Ensembl ID | ENSG00000168610 |
| UniProt ID | P40763 |
| Associated Diseases | Alzheimer's Disease; Parkinson's Disease; Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Autoimmune Encephalitis |
The STAT3 (Signal Transducer and Activator of Transcription 3) gene encodes a critical transcription factor that mediates cellular responses to cytokines and growth factors. STAT3 plays dual roles in the central nervous system - promoting neuronal survival under some conditions while contributing to neuroinflammation in others. It is activated in response to interleukin-6 (IL-6), leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), and other neuroprotective factors. Dysregulated STAT3 signaling has been implicated in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that mediates cellular responses to cytokines and growth factors. It regulates gene expression involved in cell survival, proliferation, and immune responses.
STAT3 is activated by phosphorylation in response to cytokines (IL-6, LIF, CNTF), growth factors (EGF, PDGF), and other ligands. Phosphorylated STAT3 dimerizes and translocates to the nucleus where it activates target gene transcription. STAT3 regulates genes involved in inflammation, cell survival, and differentiation. In the CNS, STAT3 is activated in astrocytes and microglia in response to neuroinflammation and plays complex roles in neurodegeneration - both pro-survival and pro-inflammatory depending on context.
Alzheimer's Disease; Parkinson's Disease; Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Autoimmune Encephalitis
STAT3 is ubiquitously expressed with high levels in the brain. It is expressed in neurons, astrocytes, microglia, and oligodendrocytes. STAT3 activation increases in the brain with aging and in neurodegenerative diseases.
STAT3 is constitutively expressed in most cell types throughout the body, including neurons, astrocytes, microglia, and oligodendrocytes in the central nervous system. In the brain, STAT3 expression is particularly high in:
STAT3 is activated by phosphorylation in response to various cytokines, growth factors, and neurotrophic factors. The JAK-STAT3 pathway is a major signaling cascade for interleukin-6 (IL-6), leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), and cardiotrophin-1 (CT-1).
The STAT3 pathway represents a promising therapeutic target for neurodegenerative diseases:
| Approach | Status | Description |
|---|---|---|
| JAK Inhibitors | Preclinical | Ruxolitinib, tofacitinib reduce neuroinflammation |
| STAT3 siRNA | Research | Gene silencing to reduce pathological STAT3 activation |
| Peptide Inhibitors | Research | Cell-penetrating peptides that block STAT3 DNA binding |
| Natural Compounds | Research | Curcumin, resveratrol modulate STAT3 signaling |
Several animal models have been used to study STAT3 in neurodegeneration:
The study of Stat3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.